Symposia: Aggressive Lymphomas: Clinical and Epidemiological
Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, Combination therapy, Clinical trials, Adult, Clinical Practice (Health Services and Quality), Bispecific Antibody Therapy, Lymphomas, Non-Hodgkin lymphoma, Drug development, Epidemiology, Chimeric Antigen Receptor (CAR)-T Cell Therapies, B Cell lymphoma, Clinical Research, Health outcomes research, Education, Diseases, Patient-reported outcomes, Treatment Considerations, Biological therapies, Aggressive lymphoma, Real-world evidence, Lymphoid Malignancies, Non-Biological therapies, Registries, Biological Processes, Technology and Procedures, Surgical, Molecular biology, Study Population, Human, Imaging, Measurable Residual Disease
Type: Poster
Hematology Disease Topics & Pathways:
Research, Combination therapy, Clinical trials, Adult, Clinical Practice (Health Services and Quality), Bispecific Antibody Therapy, Lymphomas, Non-Hodgkin lymphoma, Drug development, Epidemiology, Chimeric Antigen Receptor (CAR)-T Cell Therapies, B Cell lymphoma, Clinical Research, Health outcomes research, Education, Diseases, Patient-reported outcomes, Treatment Considerations, Biological therapies, Aggressive lymphoma, Real-world evidence, Lymphoid Malignancies, Non-Biological therapies, Registries, Biological Processes, Technology and Procedures, Surgical, Molecular biology, Study Population, Human, Imaging, Measurable Residual Disease
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H
(San Diego Convention Center)
See more of: Oral and Poster Abstracts
*signifies non-member of ASH